Clinical and laboratory characteristics of COVID-19 in the dynamics of the disease in adults: thyroid and adrenal glands
https://doi.org/10.22625/2072-6732-2024-16-2-75-80
Abstract
Objective: to evaluate the effect of COVID-19 on the development of endocrine pathology in the studied adult patients
Materials and methods: Clinical and laboratory studies were conducted in 166 patients aged 18-65 years with a confirmed diagnosis of coronavirus infection U07.1 (COVID-19); with moderate (140 patients) and severe (26 patients) course of the disease. The control group included 35 practically healthy individuals aged 18 to 65 years.
Results: In the acute period of COVID-19; the development of subclinical hypothyroidism; low T3 syndrome; subclinical thyrotoxicosis; as well as hypoand hypercortisolemia was revealed. 6 months after discharge from the hospital on an outpatient basis; the development of thyroid pathology in 6 patients and diabetes mellitus in 5 patients was revealed in COVID-19 convalescents.
About the Authors
Ya. V. MalikovaRussian Federation
Ufa
D. A. Valishin
Russian Federation
Ufa
R. T. Murzabaeva
Russian Federation
Ufa
R. G. Yapparov
Russian Federation
Ufa
References
1. Troshina E.A., Melnichenko N.G., Senushkina E.S., Mokrisheva H.G. Adaptation of the hypothalamic-pituitarythyroid and hypothalamic-pituitary-adrenal systems to a new infectious disease – COVID-19 in the context of the development of COVID-19 pneumonia and/or cytokine storm. Clinical and experimental thyroidology. 2020; 16(1): 21-27. (In Russ.)
2. Troshina Y.A., Abdulkhabirova F.M. Euthyroid sick syndrome. Problems of Endocrinology. 2001; 47(6): 34-36. (In Russ.)
3. Chashchina V.I. State of thyroid function in patients after COVID-19 illness. Innovation science. 2022; (5-1): 107-109. (In Russ.)
4. Liu F, Long X, Zhang B, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020; 18(9): 2128-2130.e2. doi: 10.1016/j.cgh.2020.04.040.
5. Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010; 47(3): 193-199. doi: 10.1007/s00592-009-0109-4.
6. Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the Endocrine System: A Mini-review. Endocrinology. 2022; 163(1): bqab203. doi: 10.1210/endocr/bqab203.
7. Urbanovych AM, Laniush F, Borovets M, Kozlovska K. Coronavirus as a trigger of Graves’ disease. Acta Endocrinol (Buchar). 2021; 17(3): 413–415. doi: 10.4183/aeb.2021.413.
8. da Silva PHA, Garcia AS, Alves FA, et al. COVID-19 and diabetes mellitus: potential metabolic associations. Curr Top Med Chem. 2021; 21(11): 929-936. doi: 10.2174/1568026621666210612025938.
9. Wang Y, Guo H, Wang G, et al. COVID-19 as a trigger for type 1 diabetes. J Clin Endocrinol Metab. 2023; 108(9): 2176- 2183. doi: 10.1210/clinem/dgad165.
10. Popescu M, Terzea DC, Carsote M, et al. COVID-19 infection: from stress-related cortisol levels to adrenal glands infarction. Rom J Morphol Embryol. 2022; 63(1): 39–48. doi: 10.47162/RJME.63.1.03.
11. COVID-19 Situation report – 51 / World Health Organization. – 2020. – URL: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (Accessed: 11.07. 2020).
12. Latrofa F, Ricci D, Bottai S, et al. Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin. Thyroid. 2018; 28(3): 288-294. doi: 10.1089/thy.2017.0052.
13. Li MY, Li L, Zhang Y, et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020; 9: 45. doi: 10.1186/s40249-020-00662-x.
14. Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: report of Hashimoto thyroiditis, Graves’ disease, and subacute thyroiditis. J Clin Transl Endocrinol Case Rep. 2021; 22: 100094. doi: 10.1016/j.jecr.2021.100094.
15. Mehta A, Awuah WA, Yarlagadda R, et al. Investigating thyroid dysfunction in the context of COVID-19 infection. Ann Med Surg (Lond). 2022; 84: 104806. doi: 10.1016/j.amsu.2022.104806.
16. Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS CoV-2’s reliance on ACE2. Endocrinology. 2020; 161: bqaa108. doi: 10.1210/endocr/bqaa108.
17. Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in Covid-19. N Engl J Med. 2020; 383(8): 789-790 doi: 10.1056/NEJMc2018688.
18. Yavropoulou MP, Tsokos GC, Chrousos GP, Sfikakis PP. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID. Clin Immunol. 2022; 245: 109133. doi: 10.1016/j.clim.2022.109133.
19. Lönnrot M, Lynch KF, Elding Larsson H, et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: The TEDDY study. Diabetologia. 2017; 60(10): 1931-1940. doi: 10.1007/s00125-017-4365-5.
20. Latrofa F, Ricci D, Montanelli L, et al. Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope. J Endocrinol Invest. 2012; 35(8): 712- 714. doi: 10.1007/BF03345804.
Review
For citations:
Malikova Ya.V., Valishin D.A., Murzabaeva R.T., Yapparov R.G. Clinical and laboratory characteristics of COVID-19 in the dynamics of the disease in adults: thyroid and adrenal glands. Journal Infectology. 2024;16(2):75-80. (In Russ.) https://doi.org/10.22625/2072-6732-2024-16-2-75-80